Goteborg, Sweden

R Nicholas Waters


Average Co-Inventor Count = 8.7

ph-index = 4

Forward Citations = 87(Granted Patents)


Location History:

  • Goteborg, SE (1995 - 1997)
  • Gothenburg, SE (1998)

Company Filing History:


Years Active: 1995-1998

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of R Nicholas Waters

Introduction

R Nicholas Waters is a notable inventor based in Goteborg, Sweden, recognized for his significant contributions within the realm of pharmacology. With four patents to his name, Waters has demonstrated a commitment to advancing the understanding and treatment of neurological disorders, particularly through his work with dopamine-related compounds.

Latest Patents

Waters' latest innovations include two noteworthy patents: "2-aminoindans as selective dopamine D3 ligands" and "Indoletetralins having dopaminergic activity." These inventions focus on developing compounds that exhibit specific interactions with dopamine receptors, which are essential for addressing conditions such as Parkinson's disease and schizophrenia.

Career Highlights

Throughout his career, Waters has played a pivotal role in pharmaceutical research, working with prestigious companies such as The Upjohn Company and Pharmacia & Upjohn Company. His efforts have contributed to the advancement of medications that improve the quality of life for individuals with neurological conditions. His career has been marked by significant research contributions that bridge the gap between scientific innovation and clinical application.

Collaborations

Waters has collaborated with esteemed colleagues in the scientific community, including Kjell A Svensson and Per A Carlsson. Together, they have worked on various projects that leverage their expertise to foster the development of innovative therapeutic solutions. These collaborations showcase the power of teamwork in driving scientific progress.

Conclusion

R Nicholas Waters has made a lasting impact in the field of pharmacology through his inventive spirit and dedication to research. His patents reflect a deep understanding of neuroscience and a commitment to developing targeted therapies that can offer hope to patients. As he continues to innovate, the potential for further advancements in the treatment of neurological disorders remains promising.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…